Clinical trial
Effect of Cladribine Treatment on Microglial Activation in the CNS
NCT04239820 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Cladribine Treatment on Microglial Activation in the CNS
- Lead sponsor
- Turku University Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 10, 2020
- Completion date
- December 31, 2025
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.